We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Itaconix Plc | LSE:ITX | London | Ordinary Share | GB00BPK3YZ68 | ORD 50P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 97.50 | 2,046 | 08:00:15 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 95.00 | 100.00 | 97.50 | 94.00 | 97.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | USD 7.87M | USD -1.54M | USD -0.1139 | -8.56 | 13.15M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 13:20:11 | O | 2,046 | 97.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/4/2025 | 07:00 | UK RNS | Itaconix PLC Grants of Options & PDMR dealings |
| 31/3/2025 | 20:25 | ALNC |  EARNINGS: Anpario profit jumps, ups dividend; Cloudcoco loss widens |
| 31/3/2025 | 07:00 | UK RNS | Itaconix PLC Preliminary Results |
| 18/3/2025 | 07:00 | UK RNS | Itaconix PLC Notice of Results and Company Presentation |
| 22/1/2025 | 18:48 | ALNC | EARNINGS: Residential Secure Income presses on with asset realisations |
| 22/1/2025 | 07:26 | ALNC | *Itaconix expects annual revenue of USD6.5m vs USD7.9m YoY |
| 22/1/2025 | 07:00 | UK RNS | Itaconix PLC Trading Update |
| 15/11/2024 | 07:00 | ALNC | IN BRIEF: Itaconix inks commercial agreement with Bonals Technologies |
| 14/11/2024 | 07:00 | UK RNS | Itaconix PLC SPARX collaboration with Bonals Technologies |
| 05/11/2024 | 12:01 | ALNC | Itaconix interim loss widens; expects revenue at upper end of guidance |
Itaconix (ITX) Share Charts1 Year Itaconix Chart |
|
1 Month Itaconix Chart |
Intraday Itaconix Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 23/4/2025 | 13:39 | Itaconix formerly Revolymer | 10,319 |
| 06/12/2022 | 16:01 | where's lucky | 38 |
| 15/7/2022 | 13:33 | GET OUT BEFORE ITS TOO LATE!!!!(11/04/02) | 149 |
| 16/6/2021 | 14:54 | Inter_X holders ready to do a big brown plop soon | 152 |
| 16/6/2021 | 14:45 | Anyone still holding any of this ? | 28 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2025-04-25 12:20:12 | 97.50 | 2,046 | 1,994.85 | O |
| 2025-04-25 10:23:40 | 92.50 | 8,341 | 7,715.43 | O |
| 2025-04-25 10:23:39 | 92.50 | 8,341 | 7,715.43 | O |
| Top Posts |
|---|
Posted at 25/4/2025 09:20 by Itaconix Daily Update Itaconix Plc is listed in the Chemicals & Chem Preps, Nec sector of the London Stock Exchange with ticker ITX. The last closing price for Itaconix was 97.50p.Itaconix currently has 13,486,122 shares in issue. The market capitalisation of Itaconix is £13,148,969. Itaconix has a price to earnings ratio (PE ratio) of -8.56. This morning ITX shares opened at 97.50p |
Posted at 16/4/2025 14:49 by gb904150 There was a moment after the last large placing when I thought ITX were on the right path. Big cash pile, growing sales, improving margins.But these last prelims show they are still way off break even. Revenue 6,503 Cost of sales (4,243) Gross profit 2,260 Administrative expenses (4,443) GM's 34.7% In order to cover their enormous SGA of $4.443m they would need to do $12.8m revs. I think they are miles away from doing that, as things stand. It strikes me as one to just sit back and wait to see if they start to grow again and can maintain their margins while doing so. Next interims will be telling imo. |
Posted at 02/4/2025 09:40 by elsol Look ADVFN team - things are not as glum as you make out:1. The new ITX strategy is successfully being delivered with increased focus on value-added performance ingredients with better margin potential - commercial is new 2024/25+ focus with SPARX and excellent web-site in place, after the clunky, unconvincing, non-impactful prior one was thankfully binned 2. Clearly ITX Board rejected the 'low profit' customer in Q2 24 from a position of pipeline knowledge and strength - short term we all thought this was a bad decision - but in hindsight it was an informed, commercially savvy decision that is value maximising for ITX in the medium term 3. The US tariff impact issue has been well over-feared as observed in Q1 share price decline - it was clearly communicated on 31 March by John that they do not consider it as a significant issue since (a) most ITX costs are US derived costs,(b) possibility of Canada supply-side competitive benefit as US manufacturer and (c) some levers to pull on COGS reduction as ITX grows to mitigate any otherwise adverse impact 4. Professional investor round was 5.1p-ish in old money (pre-consolidation). We are at roughly half that level right now with a 2025F heading close to $10m sales and cusp of breakeven and reduced cash burn. Val Multiple is only 1.7ish at EV/sales level for 2025 so large upside from this 'cheap as chips' base value aligned to, say, 2.6p in old currency. 5. Admittedly, we were all taken in with the large uplift to 15p/share which was inappropriate for sure but equally we are now on the other side of the range entirely at 2.6p/share (old money equivalent) - neither are correctly aligned to ITX value today, but there is now large upside on a value / risk balance grounds - that's why I topped-up quite a bit at 126.4. |
Posted at 01/4/2025 19:35 by elsol Hi PATT, the company are obtaining 40%+ GMs on some products. But agree it is all about increasing volumes/revs. and maintaining fixed costs which looks doable given small size of ITX. |
Posted at 01/4/2025 14:39 by elsol Also re-posting LSE summary of new Broker note @31st March - some interesting granular details to call out within Broker report (and company RNS now had time for a full review):• REVENUE GROWTH SEGMENTS 2025/26F: Broker view “We continue to see Hygiene and Beauty segment as major long-term drivers for Itaconix growth, both in existing applications and with new polymer families” - This year, 2025 - Hygiene (Zinador, Velafresh) growth at 94%; Beauty (Velasoft, Amaze SP) growth at 83%; • REVENUES EUROPE: Cleaning grew by 100% in FY2024 and now makes up almost 30% of global sales (major geographic re-balancing of clients/derisking portfolio); • FUTURE DIVERSIFICATION CHANNELS: 2026F – new diversification product applications anticipated to make up 11% of global sales (beyond cleaning, hygiene and beauty); • GROSS MARGIN: 2025F & 2026F gross margin expected to grow from 35% to 38% (+3% above 2024), even with current tariff impacts worked-in; • CAPEX: FY25+26F – Total capex of $2.85m – again this is big investment for plant re-tooling and replacement / enhancement spending – seems bullish for growth to support material plant op. capacity and revenue uptick; • WC: Working capital growth well below revenue growth – op. / financial efficiency • BS CASH: Net cash at end of FY 2026F of $2.6m (+21 months away) – taking us beyond breakeven so no assumed additional cash call / dilution is the Broker assumption; • VALAUTION MULTIPLES: Currently EV/Sales (x) of only 1.7x sales for current year, so ITX appears to be materially undervalued given the presence of major off balance sheet IP assets (16 patent families covering proprietary processes, compositions and applications) that ringfence the itaconate polymerisation technology platform. In my mind this collective patent estate is the real gold stored in the ITX vault that underpins the large upside value of ITX in near term; • TARGET PRICE: Broker commentary: “Our unchanged price target of 325p is based on a combination of EV/sales multiples for perceived peers and a potential take-out value.” - The latter has not been described quite like this before I don’t believe but given the above you can see why – protected growth with margin expansion possibilities for larger business combination. |
Posted at 01/4/2025 14:30 by rivaldo Some useful notes on LSE on ITX's results presentation from Smartinvestment:"There were some big positives for me today: - we have been promised more regular RNS. - SPARX is on track and we can expect to hear more progress during the rest of the year. - I know some might be disappointed about Superabsorbents but I think John’s answer was excellent. In short, “we are interested in development that translates into purchase orders”. They have plenty of other products to focus on driving income and gross margin and I applaud their stance. - Early/Mid July for H1 2025 isn’t far away and we know things are on track. - No plans for European plant at present and 6.7m cash on books so I have no worries about fund raise in next 2 years. - Really like that they are looking for gross margins over 40% on new business. - Good answer on share price fluctuations. Thin volume to trade which will benefit us when the share price starts going up which I think is now onwards. Overall 9/10 on performance. They answered all questions openly and honestly and I like their no nonsense approach that they are hear to make money!" "...there are 10 SPARX collaborations confirmed in 2025. This includes the new North American detergent tablet innovation centre with Bonals. The first major new end product will be on the market in North America early 2026 with additional new major end-products in 2027. Each product has multiple applications and each application has multiple sales possibilities. This will drive massive future revenue expansion. In the meantime, they are growing revenue to 9.6m this year with existing products and applications which is impressive growth in its own right. Sorry you are disappointed about superabsorbents but if it ain’t translating into purchase orders why would the company pursue this particular product when they have so many other products and applications that are translating into purchase orders." |
Posted at 31/3/2025 12:43 by purchaseatthetop What about “ITX, cleans out PIs”? |
Posted at 31/3/2025 12:40 by lefrene NC, it's never got away from the typical AiM business model of talking up their supper, but somehow never quite delivering on the talk. The sunlit uplands are always 18 months to 2 years away.Perhaps they need to launch their own detergent brand? 'ITX' cleans clothes, no phosphates. |
Posted at 04/2/2025 09:26 by lefrene The actual business looks like it is making progress, but we do seem on the cusp of a wider market sell off, in which case ITX not being a profit earner will likely get hit some more by people needing to raise cash. I'm sticking with it as it seems close to becoming an actual business. I would like to see the price improve, and the thing reflect the value in the patents and future prospects of value in phosphate reductions. Although I suspect once politics gets behind phosphate reduction, then we will see a big hitter wade in and buy up the little guys to gain the technology on the cheap. |
Posted at 22/1/2025 12:03 by lefrene It's not beyond ITX to create their own itaconic acid, perhaps in partnership with others who also consume this base product?If Trump is going to remove a lot of regulation stumbling blocks, then it should become quicker and easier to establish businesses, and create jobs and boost the consumer. Whereas here we are going to heap even more tax upon the poorest of the working poor, by cutting part time work from £9,100 to £5000, and upping bus fares by 50%, directly taking disposable income from the group that feeds what little income they have, fastest back into the economy. I suspect Trump will be good for USA business, and thus good for ITX In the meantime ITX is burning £30k a week of investors money, that they have charmed from the market. If ITX finally becomes an actual business they will at least have a big tax asset in those accumulated losses. In the meantime it looks like the market is underwhelmed by the update. Perhaps one of the big hitters might come along to take it out, whilst it's back on the floor again? |
Posted at 02/4/2024 19:15 by elsol PTT,The new Fcst 24 is an optical financial worst case scenario (low case) assuming the worst outcome and total loss of revenues going forwards for this client (a client that appears to have v low profitability overall and hence low contribution to the value of the firm in totality irrespective to its total revenue - in all probability we will not see the worst case evolve into the actual revenue outturn since the party may order more than the worst case for the rest of FY 24 and may return in FY25. In any case much of the value of ITX is not currently generating revenue but has value nevertheless. Its subsumed in the share price so my take is yes we may have lost a chunk of revenue - its not really profitable so times by, say, 75% then consider R&D projects overlay value so you cannot say we lost x% revenue and that translates to x% share price fall as we are dealing with apples (profitable revenue) and oranges (non-profitable revenue and grapefruit (future much bigger very profitable revenues) that can occupy the plant capacity. See my note on LSE chat re: plant capacity and value maximisation of total ITX portfolio (existing and new customers) which may mean the decision today is actually value accretive as a portfolio rather than destroying value. Its a strange concept but one you have to get your head around with this stock if you are serious medium term invetor. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
.png){kind=logo}
